[Can serum estradiol predict the effect of raloxifene on breast cancer risk?].
von Schoultz
Eva
E
Bröstenheten, Radiumhemmet, Karolinska sjukhuset, Stockholm. eva.von.schoultz@ks.se
D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000517:prevention & control; D004958:Estradiol / Q000097:blood*; D004965:Estrogen Antagonists / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage*
D014408:Biomarkers, Tumor; D004965:Estrogen Antagonists; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; D004958:Estradiol